EUVIMEDOpdag EUVIMED
Open access

Targeting macrophage circadian rhythms with microcurrent stimulation to activate cancer immunity through phagocytic defense

Yuya Yoshida, Tomohito Tanihara, Keika Hamasaki, Fumiaki Tsurusaki, Taiki Fukuda, Satoka Adachi, Yuma Terada, Kaita Otsuki, Naoki Nishikawa, Kohei Fukuoka, Ryotaro Tsukamoto, Kengo Hamamura and 6 more

Theranostics · 2025

DOI: 10.7150/thno.100748 ↗

At a glance

Journal article in Theranostics, 2025. Written by Yuya Yoshida and 17 co-authors. Institution: Department of Clinical Pharmacokinetics, Faculty of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi Higashi-ku, Fukuoka 812-8582, Japan. Major MEDLINE topics: Phagocytosis, Circadian Rhythm, Macrophages, Neoplasms. Cited 9 times so far (Crossref). The full text is freely available in PubMed Central.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Rationale

Macrophage phagocytosis plays a role in cancer immunotherapy. The phagocytic activity of macrophages, regulated by circadian clock genes, shows time-dependent variation. Intervening in the circadian clock machinery of macrophages is a potentially novel approach to cancer immunotherapy; however, data on this approach are scarce. Microcurrent stimulation (MCS) promotes inflammation, proliferation, and remodeling, suggesting its potential to modulate macrophage function; however, its application has been limited. In this study, we investigated the impact of MCS on macrophage phagocytosis of cancer cells using mouse/human macrophage cell lines and various mouse/human cancer cell lines.

Methods

Cells and mice received 300 µA, 400 Hz bidirectional pulsed MCS. Gene expression, protein expression, and phagocytosis activity were assessed in intraperitoneal macrophages collected from mice, as well as in RAW264.7, and THP-1 cells. Flow cytometry, population, phagocytosis activity, RNA-seq, and immunohistochemistry analyses were performed.

Results

Noninvasive MCS prevented time-dependent reduction in macrophage phagocytosis of cancer cells by modulating the circadian clock genes. MCS also enhanced phagocytosis in mouse RAW264.7 and human THP-1 cells across various cancer types by promoting actin polymerization; similar in vivo effects were observed in mice. This enhancement occurred in abdominal macrophages of both sexes and was mediated by changes in clock gene expression. Specifically, suppressing the clock gene Per1 nullified the effects of MCS. Moreover, although macrophage phagocytosis typically declined during the dark period, MCS during the light period prevented this reduction. MCS also increased phagocytosis of peritoneally implanted cancer cells (4T1, ID8, and Hepa1-6) in mice, significantly reducing tumor engraftment and growth, and ultimately improving prognosis.

Conclusions

The findings of this study suggest that targeting macrophage circadian mechanisms via MCS could enhance cancer immunity, offering new avenues for cancer immunotherapy.

Subjects

MeSH terms (MEDLINE)

PhagocytosisCircadian RhythmMacrophagesNeoplasmsAnimalsMiceHumansRAW 264.7 CellsCell Line, TumorImmunotherapyMaleTHP-1 CellsFemaleMice, Inbred C57BL

Author keywords

cancer immunotherapycircadian rhythmmacrophagemicrocurrent stimulationphagocytosis

Authors and institutions

  • Department of Clinical Pharmacokinetics, Faculty of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi Higashi-ku, Fukuoka 812-8582, Japan.
  • Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi Higashi-ku, Fukuoka 812-8582, Japan.
  • Department of Biological Science and Technology, Faculty of Advanced Engineering, Tokyo University of Science, 1-3 Kagurazaka, Shinjuku-ku, Tokyo 162-8601, Japan.
  • Department of Drug Discovery Structural Biology, Faculty of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi Higashi-ku, Fukuoka 812-8582, Japan.

Cite

APA

Yoshida, Y., Tanihara, T., Hamasaki, K., Tsurusaki, F., Fukuda, T., Adachi, S., Terada, Y., Otsuki, K., Nishikawa, N., Fukuoka, K., Tsukamoto, R., Hamamura, K., Oyama, K., Tsuruta, A., Mayanagi, K., Koyanagi, S., Ohdo, S., & Matsunaga, N. (2025). Targeting macrophage circadian rhythms with microcurrent stimulation to activate cancer immunity through phagocytic defense. Theranostics. https://doi.org/10.7150/thno.100748

Vancouver

Yoshida Y, Tanihara T, Hamasaki K, Tsurusaki F, Fukuda T, Adachi S, et al. Targeting macrophage circadian rhythms with microcurrent stimulation to activate cancer immunity through phagocytic defense. Theranostics. 2025. doi:10.7150/thno.100748

BibTeX
@article{Yoshida2025,
  author = {Yoshida, Yuya and Tanihara, Tomohito and Hamasaki, Keika and Tsurusaki, Fumiaki and Fukuda, Taiki and Adachi, Satoka and Terada, Yuma and Otsuki, Kaita and Nishikawa, Naoki and Fukuoka, Kohei and Tsukamoto, Ryotaro and Hamamura, Kengo and Oyama, Kosuke and Tsuruta, Akito and Mayanagi, Kouta and Koyanagi, Satoru and Ohdo, Shigehiro and Matsunaga, Naoya},
  title = {Targeting macrophage circadian rhythms with microcurrent stimulation to activate cancer immunity through phagocytic defense},
  journal = {Theranostics},
  year = {2025},
  doi = {10.7150/thno.100748}
}
Start for free →